Trial intelligence / Profile preview

Botox A for surgical neck wound scarring

NCT01177358Phase 2Completed

Sponsor
Nova Scotia Health
Start
May 2010
Primary completion
May 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in scar, sponsored by Nova Scotia Health. Started May 2010; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

scar

Beyond the preview

Go deeper on NCT01177358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01177358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call